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Despite the documented health beneﬁts of physical ex-
ercise, there is a paradoxical, but small, risk of sudden
cardiac arrest (SCA) and/or death (SCD) associated with
exercise. Cardiovascular causes account for 75% of sport-
related deaths in young athletes, with SCA/SCD rates
varying according to athlete age, gender, intensity of ac-
tivity, race, and ethnicity. True risk for American athletes
is difﬁcult to assess owing to the lack of a national registry
with well-deﬁned numerators and denominators, and a
consensus on metrics. Although exercise-related syncope
and/or chest pain are considered the most ominous pro-
dromal complaints, the true predictive value of symptoms
is not known in athletic populations. The comparative
effectiveness of various screening methodologies (e.g.
history and physical alone versus history and physical
plus electrocardiogram) with regard to athlete outcomes
has not been determined. To address these issues in
American athletes, and to coordinate a nation-wide
multidisciplinary approach to athlete cardiovascular
care, the American College of Cardiology Sports and Ex-
ercise Cardiology Section convened the “Think Tank to
Protect the Heart of the American Athlete and Exercising
Individual” on October 18, 2012, in Washington, DC. Think
Tank participants (representing athletic trainers; primary
care professional societies; cardiovascular specialty, sub-
specialty, and imaging societies; government agencies;
industry; sports governing bodies; and patient advocacy
groups) identiﬁed 92 quality gaps, and created an action
plan to address the most urgent of these gaps: 1) Deﬁning
sports cardiology outcome metrics and conducting high-
quality epidemiologic research; 2) Educating providersin the optimal use of existing clinical athlete cardiovas-
cular care tools; 3) Promoting and conducting research
to deﬁne normative values for cardiac tests in large
numbers of American athletes and developing data-
driven management algorithms; and 4) Coordinating
athlete advocacy efforts by creating athlete cardiovas-
cular care state-wide task forces. The Think Tank plans to
convene every 2 years to monitor progress.INTRODUCTION
Regular physical activity confers numerous health bene-
ﬁts for individuals of all ages (1–5). Current United States
physical activity guidelines recommend that healthy
adults accumulate 2.5 hours of moderate activity per
week and children accumulate at least 60 minutes of daily
physical activity, with 20-30 minutes of vigorous activity
3 days per week for both age groups (6). Although these
recommendations have resulted in record numbers of
Americans participating in sports and exercise in all major
demographic groups (7–9), the vast majority of the U.S.
population is sedentary (10).
Despite the beneﬁts of physical exercise, there is a
paradoxical, but small, risk of sudden cardiac arrest (SCA)
and/or death (SCD) associated with exercise (11). Attempts
to reduce the incidence of SCA/SCD by adding resting
electrocardiograms (ECG) to athlete pre-participation
evaluation (PPE) in the United States have led to robust
debate regarding the comparative effectiveness of
screening strategies with regard to outcomes (12,13). This
debate has contributed to the growing discipline of sports
and exercise cardiology in the United States, and to the
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2148expanding role of the cardiologist as a member of the
athlete healthcare team (14).
Numerous multidisciplinary groups are addressing
athlete cardiovascular care issues with the goal of
improving athlete safety (14–19). Several states have
introduced or passed SCA/SCD-related legislation to
regulate athlete PPE screening; require automated
external deﬁbrillators (AEDs) in all schools; and/or
educate parents, students, coaches and athletic staff
regarding risk, symptoms, and treatment (20,21). Patient
advocacy groups are promoting awareness of SCA/SCD
causes and consequences in children, adolescents, and
young adults (22–24), and federal funding agencies (the
National Institutes of Health and Center for Disease
Control and Prevention) have reviewed the subject with
expert panels (25).
The American College of Cardiology (ACC) Sports and
Exercise Cardiology Section convened the “Think Tank to
Protect the Heart of the American Athlete and Exercising
Individual” on October 18, 2012, in Washington, DC. Its
purpose was to bring together a broad range of stake-
holders who provide cardiovascular care to American
athletes, to identify quality gaps in existing care, and to
create speciﬁc, multidisciplinary solutions to improve
care. “Think Tank” participants represented athletic
trainers; primary care professional societies; cardiovas-
cular specialty, subspecialty, and imaging societies; gov-
ernment agencies; industry; sports governing bodies; and
patient advocacy groups. Through interactive discussions
regarding risks to athletes, the meaning of symptoms, and
primary and secondary prevention of SCA/SCD in ath-
letes, the work group identiﬁed 92 quality gaps in four
major domains: 1) Quantifying risks to American athletes;
2) Education, and optimal use of existing clinical athlete
care tools; 3) Research, quality, and science; and 4)
Advocacy and communications. Once these gaps were
identiﬁed, Think Tank organizers prioritized gaps
depending on their level of urgency and, over the next
year and a half, continued their dialogue, incorporated
most recent research, and compiled their recommenda-
tions. This report summarizes the ﬁndings of the Think
Tank participants and authors, providing a practical ac-
tion plan to optimize American athlete cardiovascular
health.
SECTION 1. THE AMERICAN ATHLETE
AND RISKS OF PARTICIPATION
There is no universally accepted deﬁnition of an athlete.
Merriam Webster deﬁnes an athlete as “a person who is
trained or skilled in exercises, sports, or games requiring
physical strength, agility, or stamina” (26). The ACCF 36th
Bethesda Conference deﬁnition adds the concepts of
regular competition against others and organizedprograms, which is more easily applied to high school,
college, professional teams, and masters athletes but ex-
cludes those who are involved in high-level physical ac-
tivity away from competition or in organized groups (15).
In reality, American athletes come in all ages and sizes
with differing cardiac demands and adaptations to sport
depending on the combination of static and dynamic
components of the activity (15,16). For the purposes of this
document, we deﬁne the American athlete as any individual
who engages in routine vigorous physical exercise in the
settings of competition, recreation, or occupation (14).
Participation
Sports participation can begin by age 4 to 6 years and
continue through masters competitions in the later
decades of life. Over 35 million U.S. youth aged 5 to 18
years (52% of girls and 62% of boys) participate in orga-
nized team and individual sports in scholastic (40%) and
non-scholastic (60%) settings (27). Within this group,
approximately 7.7 million boys and girls participated in
varsity program U.S. high school sports seasons in the
2011-12 academic year (27). Over 450,000 student-
athletes participate in organized sports at the collegiate
level in the United States (28). These numbers do not
include youth athletes and young adults participating
in “off the grid” activities such as backcountry skiing,
snowboarding, surﬁng, mountaineering, cycling, and
BMX biking. In addition, the number of middle-aged
and older adults participating in organized sports is
growing. Running USA tracks road race participation
and found there were nearly 14 million ﬁnishers (55% of
them women) in 2011, up from 5.2 million in 1991 (29),
and that the number of marathoner ﬁnishers over age
55 more than doubled (from 32,500 to 76,500) between
1992 and 2008 (29).
Cardiac Development and Adaptation
Although somatotype (e.g., football linemen versus dis-
tance runners) may inﬂuence sport selection, cardiac ad-
aptations are most affected by the cardiovascular
demands of the activity. Dynamic exercise substantially
increases maximum oxygen consumption, cardiac output,
stroke volume, and systolic blood pressure, with an
associated decrease in peripheral vascular resistance. In
contrast, static exercise leads to increases in diastolic
blood pressure, peripheral vascular resistance, and heart
rate. Long-term adaptations to endurance training lead to
cardiac remodeling secondary to both volume ﬂow and
increased cardiac output, whereas strength-based exer-
cise causes a predominant pressure effect, with minimal
increase in cardiac output (15,30).
The heart grows as a child grows in physical stature,
with accelerated cardiac growth through puberty (31). The
heart is a muscle and responds to exercise loads with left
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2149ventricular hypertrophy. As is the case with skeletal
muscle, the heart muscle’s thickness can decrease with
detraining. Children can participate in physical training
and show improvements in VO2max, but changes are
generally modest and are inﬂuenced by age, onset of
puberty, and type of training (32). Absolute VO2max
values (l/kg) also increase with growth to age 18 in boys
and to age 14 in girls (33). Relative to adults, at any level
of VO2max, children have a higher heart rate and arte-
riovenous oxygen extraction, and lower systolic and dia-
stolic blood pressure, stroke volume, cardiac output, and
anaerobic metabolism. Endurance aerobic training in
children can produce a 5% to 6% increase in peak VO2,
and with high training volume plus consistent intensity
of >80% maximum heart rate, peak VO2 can rise
8%-10% (34).
Other adaptations to exercise include increased left
ventricular diastolic volume, increased vagal tone, and
benign arrhythmias like sinus bradycardia, ﬁrst-degree
atrioventricular block, and incomplete right bundle
branch block. It has been speculated that long-term
endurance activity (e.g., Nordic skiing) may lead to cell
damage or cardiac disease (34a). Almost all studies
performed in middle-aged and older endurance athletes
have observed a greater risk of atrial ﬁbrillation for these
athletes than for non-athlete controls (35,35a). Interested
readers are referred to these excellent reviews on this
subject (35,35a). Similarly, recent studies of athletes
following intense endurance exercise have shown an
acute increase in troponin and B-natriuretic peptide
(BNP) levels (36). This acute myocardial damage could
lead to subsequent ﬁbrotic remodeling of the ventricular
myocardium that may act as a substrate for fatal
arrhythmias (37). Given the complexities of the heart
response to exercise, it is clear that deﬁning normative
data for the wide range of American athletes participating
in all types of sports is paramount.TABLE 1 Reported SCD Incidence in the American General Adol
Population Reference #
General population (12-19 years of age) Atkins, 114
MSHSL athletes (12-19 years of age) Roberts, 75
MSHSL athletes (12-18 years of age) Maron, 76
NCAA athletes (exercise-related) Harmon, 42
NCAA athletes "
NCAA male athletes "
NCAA black athletes "
Male NCAA Division I basketball athletes "
*All SCD in adolescents: athlete, and non-athlete, and regardless of activity. †Includes only SC
MSHSL-age athletes, regardless of activity level at time of SCD. §Includes only SCDs occurrin
during competition, practice, sleep, or when the athlete is off with injury.
MSHSL indicates Minnesota State High School League; NCAA, National Collegiate AthleticRisk of SCD
SCD risk increases with physical activity intensity and is
greatest in sedentary individuals during exercise (38).
Exercise-associated SCA/SCD is arbitrarily deﬁned as
occurring during or within an hour of physical activity,
and although exercise-related death is rare overall, 75% of
sport-related deaths in young athletes are from cardio-
vascular causes (39). In athletes under 35 years of age,
exercise-related SCA/SCD is usually associated with
structural or electrical cardiac abnormalities, including
cardiomyopathies, coronary artery anomalies, channelo-
pathies, congenital heart defects, acquired myocarditis,
and genetic syndromes (39–43).
It is likely that SCA/SCD risk varies with age, gender,
intensity of activity, race, and ethnicity (Table 1). The true
risk for U.S. athletes is difﬁcult to assess because there is
neither a national registry with well-deﬁned numerators
and denominators nor consensus on metrics. Should both
resuscitated SCA and SCD be included in the numerator?
Should all athletes be included in both the numerator and
the denominator, or only those performing sports or ac-
tivity at the time of SCA/SCD? Athlete SCA/SCD can be
deﬁned as an episode occurring during or within 1 hour
of exercise (44,45). However, some investigators include
all athletes in a well-deﬁned demographic in the rate
equation, regardless of whether SCA/SCD occurred
during sleep or exercise or while out with injury (42).
Differences in methodology can produce conﬂicting re-
sults (Table 1); SCA/SCD rates may vary by as much as
50%-75%, depending on whether one uses only those
athletes exercising at the time of SCA/SCD or all athletes
in a deﬁned demographic (42,45,46). Whereas the former
measures the risk of exercise as a trigger, the latter may
measure the risk of being an athlete. Both may be valid,
given that exercise is a known trigger for SCA/SCD (38,39),
whereas training adaptations and chronic effects of ex-
ercise render the athlete heart a different substrate fromescent Population and in Young Athletes
Includes Resuscitated SCA
Incidence of SCD per 100,000
Person- or Athlete-Years
Yes 6.37*
No 0.24†
No 0.7‡
No 1.37§
" 2.28k
" 3.02k
" 5.65k
" 31.99k
Ds occurring during MSHSL-sponsored game or practice. ‡Includes SCDs occurring in all
g during exertion in NCAA athletes. kIncludes all NCAA athlete SCDs, whether occurring
Association; SCA, sudden cardiac arrest; SCD, sudden cardiac death.
TABLE 2
Reference Ranges Anatomy and Diagnostic
Parameters Based on Age (Years) and Intensity
Child 5-11
Adolescent
Early 12-14
High school* 15-18
College* 19-22
Young adult 23-34
Middle age adult 35-64
Aging adult 65 and beyond
*Usual ages for U.S. and college athletes. U.S. eligibility for sports ranges from ages
11 through 19 and college athletes can range up to age 25 in ice hockey and older
in football.
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groups varies around the country, further confounding
the risk equation. Risks should be determined for the
varying athletic populations; and approaches to screening
should be tailored on the basis of known risks.
Reﬁning Athlete Age and Competition Classiﬁcations
The explosion of organized sporting activities for children
presents parents with a variety of activities to choose for
their children, ranging from entry-level sports participa-
tion to year-round “travel teams” with training schedules
and competitions that rival college sports. Youth leagues
are usually classiﬁed by age and/or skill level; however,
young adolescent physical maturation should be consid-
ered because not all 12 year olds are created equal. Some
children have focused sports-speciﬁc goals and begin
vigorous training regimens by age 10 or even younger. For
children, the competitive level, age and size of partici-
pants, and training intensity all represent important var-
iables in determining safe participation from a risk:beneﬁt
perspective.
For athlete evaluation, screening and diagnostic in-
terventions likely need athlete-speciﬁc norms and more
reﬁned age groups than “adult” and “child” to make
reasonable cardiovascular risk decisions regarding
participation. It is important that data speciﬁc to a
particular athlete age group, genetic predisposition, sex,
or intensity level not be extrapolated to make policy de-
cisions for other athlete groups (e.g., college data applied
to high school age athletes). Suggested age groupings that
likely reﬂect both age and intensity for the majority of the
population are listed in Table 2.
SECTION 2. MEANING OF SYMPTOMS IN ATHLETES
Syncope and Collapse
The ultimate symptom of underlying heart disease is an
episode of SCA/SCD. Studies of youth who have experi-
enced SCA/SCD ﬁnd that approximately 50% reported
antecedent symptoms (47). This can vary by condition. Of
those with long QT syndrome, 10%-30% present with
SCA/SCD as a ﬁrst symptom (48). Syncope and collapse
are among the most troublesome problems and yet, no
consensus or evidence-based management approach ex-
ists for athletes, and epidemiological data in this group
are scant.
Risk may depend upon the setting in which syncope
occurs. As a general observation, syncope or collapse that
occurs during or prior to completion of an event is more
likely to represent cardiac or other concerning etiologies,
whereas collapse following an event, especially an
endurance event, may represent a more benign etiology.
In a non-athletic general population of American
patients #18 years, symptoms occurred during activity in65% with cardiac syncope, compared with 18% in those
with vasovagal syncope (49). In a study of young Euro-
pean athletes, 6.2% of 7,568 athletes (mean age 16.2  2.4
years) reported having had at least one syncopal episode
within the preceding 5 years (50). These episodes were
not related to exercise (86.7% of all episodes), occurred
immediately after exercise (12.0%), or during exercise
(1.3%). Although syncope occurring during exercise was
rare overall (0.08% of the whole study population), un-
derlying cardiac pathology was found in 33% of those who
experienced syncope during exercise (50). Similar data
have not been obtained in large numbers of American
athletes.
In another European study of 33 athletes (mean
age 21.4  3.2 years) referred for recurrent episodes of
exercise-related syncope (mean number of episodes be-
fore evaluation was 4.66  1.97), 12.1% developed hypo-
tension associated with pre-syncope during maximal
exercise testing, and 22 subjects (66.6%) showed a posi-
tive response to head-up tilt testing (51). Underlying
high-risk cardiac conditions were not present in this
group, but recurrence of syncope was common over the
follow-up period. All studies considered, the widely held
belief that syncope during exercise is more likely to be of
cardiac cause appears to be true. However, recurrent
episodes of exercise related-syncope appear to be asso-
ciated with a more benign course. Associated chest pain
or discomfort should be considered an ominous sign.
Older studies in non-athletic populations suggest that
experiencing fewer than 2 syncopal episodes or a
warning #5 seconds is more predictive of syncope due to
ventricular rhythm or atrioventricular block than to syn-
cope arising from other causes. In contrast, prodromal
palpitations, blurred vision, nausea, warmth, diaphoresis,
lightheadedness, and warning lasting >5 seconds are
more predictive of neurocardiogenic syncope (51a) than of
syncope due to other causes. Similar data has not yet been
generated in athletic populations.
In the sports medicine literature, the term “exercise-
associated collapse” (EAC) has been coined to describe
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2151episodes of collapse, but not necessarily syncope with
loss of consciousness (52–55). EAC is deﬁned as acute loss
of voluntary muscular tone resulting in a fall to the
ground in athletes who are conscious but unable to stand
or walk unaided as a result of light-headedness, faintness,
and dizziness that occurs after completion of an exer-
tional event or stopping exercise. True syncope with loss
of consciousness can also occur in the setting of EAC, but
EAC is associated with a rapid return of consciousness in
the supine position and generally with a prolonged period
of weakness or fatigue. Although the mechanism(s) for
EAC are multifactorial, EAC is thought to be principally
the result of transient postural hypotension caused by
either lower extremity pooling of blood once the athlete
stops running and the resultant overwhelming of normal
autonomic compensatory mechanisms, or an inappro-
priate neurally mediated reﬂex (52–55). It has been
demonstrated that collapse in marathon runners accounts
for 59% of ﬁnish area medical encounters and affects
1.4% of ﬁnishers (56). Although EAC is common, cardiac
syncope is part of the differential diagnosis and must be
ruled out from the benign forms of EAC. Distinguishing
between syncope and EAC involves a long differential and
the reader is referred to comprehensive reviews on this
topic (52–55).
Potential cardiac etiologies and suggested work ups are
listed in Table 3. Although these etiologies constitute
most of the life-threatening causes of syncope and
collapse, heat stroke should also be considered for
collapsed athletes with prolonged exposure to high tem-
peratures and humidity. Unless the athlete passes out
during monitoring, results of testing are suspect and
thoughtful consideration is needed to determine the best
approach and methodology to quantify risk and under-
stand the syncopal episode. The phrase “unknown syn-
cope” is too vague, especially when considering return to
play and eligibility questions, and should be avoided.
Depending on the severity and recurrence of episodes, an
appropriate approach to restricting the athlete’s activities
needs to be deﬁned. For those who undergo treatment, a
follow-up plan based on sport and the clinical presenta-
tion and data-driven return-to-play guidelines need to be
developed.
Chest Discomfort
Among athletes <35 years, chest pain (CP) is generally
non-cardiac in origin. Indeed, <5% of CP in athletes in this
age group is considered cardiac (57). Gastroesophageal
reﬂux is the most common organic cause of CP, followed
by exercise-induced bronchospasm. In older athletes,
cardiogenic CP is more common, accounting for approxi-
mately 16% of cases of CP, with musculoskeletal and
gastrointestinal reﬂux accounting for 36% and 13%,
respectively. (57). Differential diagnosis of cardiac causesof CP, and suggested work-ups are listed in Table 3.
Exertional CP (e.g., angina) occurs in up to 30% of pa-
tients with hypertrophic cardiomyopathy (58) and is the
most common cause of SCD in young athletes. In some
patients with hypertrophic cardiomyopathy, CP may be
atypical, occurring at rest or with meals (58). Aortic
dissection causes acute CP and may be associated with
congenital bicuspid aortic valve disease, Marfan’s syn-
drome, Ehlers-Danlos syndrome, cocaine abuse, and
weightlifting (59). There is an exhaustive differential for
CP in athletes (57).
Cardiac causes must be considered ﬁrst (even if
brieﬂy) so as not to miss high-risk, potentially lethal
conditions. Once cardiac CP has been excluded, more
common etiologies can be explored. Although a 12-lead
ECG (15 lead in children/youth) should be performed
for any athlete with CP, even a “normal” ECG should be
interpreted with caution. Beyond the ECG, echocardiog-
raphy should be performed when cardiac CP is sus-
pected, and interpreted according to the athlete’s sport,
race, gender, age and body size. Studies looking at cau-
ses of CP in athletes are lacking; therefore, large-scale,
prospective epidemiologic studies are needed to deﬁne
the predictive value of CP in diagnosing underlying
cardiac disease in athletes.
Palpitations
Although palpitations are not one of the 12 AHA ele-
ments (16), exercise-related palpitations are included in
history form questions in the 4th PPE monograph (60).
The incidence in athletes varies, from 0.3% to 70%, with
palpitations from all causes being much less common in
young, school-age athletes but more common in highly
trained and older athletes (61). The history should focus
on the timing of palpitations (day, night, while trying to
go to sleep, during exercise, before an event); presence
of social stressors; supplement, alcohol, recreational
drug, and caffeine intake; associated symptoms, partic-
ularly syncope or near syncope (see Syncope section);
a precise description of sensation, including sudden
onset and/or cessation; duration of symptoms; and any
family history of sudden death in relatives #50 years old
or inheritable cardiac disease. Differential diagnosis of
cardiac causes of palpitations, and suggested work ups
are listed in Table 3.
Atrial ﬁbrillation may be more common in com-
petitive athletes than in the general population, particu-
larly in those with a long-standing history of endurance
sports participation (35). Return-to-play (RTP) deci-
sions are based on symptom severity, persistence of the
arrhythmia, impact on athletic performance, type and
need of treatment, rate and rhythm during sports, and
underlying cardiac diagnosis (15). Readers are referred to
these excellent recent reviews on this subject (35,35a).
TABLE 3 Suspected Etiologies and Suggested Work-Up for Speciﬁc Symptoms in Athletes
Symptom Possible Cardiovascular Diagnostic Imaging Suspected Etiologies
Chest Pain  Electrocardiogram
 Echocardiogram
 Chest X-ray
 Exercise stress test
 Cardiopulmonary exercise test
 Exercise echocardiogram/nuclear imaging
 Cardiac/Aortic/Pulmonary CT angiogram
 Cardiac MRI
 24-hour ambulatory monitoring
 Event monitor
 Anomalous coronaries
 Exercise-induced bronchoconstriction
 Valvular heart disease
 HCM
 Other cardiomyopathies: DCM, RCM, LVNC, ARVC
 Ischemic heart disease
 Pulmonary embolism
 Aortic dissection
 Peri/Myocarditis
 Congenital heart disease
 Arrhythmias
Syncope  Electrocardiogram
 Exercise stress test
 Echocardiogram
 Cardiac MRI
 Cardiac CT angiogram
 24-hour ambulatory monitoring
 Event monitor
 Implantable loop recorder
 Cardiomyopathies: HCM, DCM, RCM, LVNC
 ARVC
 Valvular heart disease
 Anomalous coronaries
 Congenital heart disease
 Brugada syndrome
 Long QT syndrome
 Catecholaminergic polymorphic ventricular tachycardia
 Atrial and ventricular tachyarrhythmias
 Ischemic heart disease
Palpitations  Electrocardiogram
 24-hour ambulatory monitoring
 Event monitor
 Exercise stress test
 CBC, electrolytes, TSH, plasma metanephrines
 Premature atrial and ventricular contractions
 Atrial and ventricular tachyarrhythmias
 AV block, 2nd or 3rd degree
 Anemia
 Electrolyte disturbances
 Thyroid and other endocrine disorders
Dyspnea  Echocardiogram
 Cardiopulmonary exercise test
 Pulmonary function test
 Chest X-ray
 Exercise echocardiogram
 CBC, ferritin
 Anomalous coronaries
 Asthma
 Exercise-induced bronchoconstriction
 Valvular heart disease
 Cardiomyopathies
 Ischemic heart disease
 Pulmonary embolism
 Congenital heart disease
 Anemia
Fatigue  CBC, ferritin, glucose, electrolytes, TSH
 Echocardiogram
 Cardiopulmonary exercise test
 Anemia
 Electrolyte disturbances
 Thyroid disorders
 Cardiomyopathies
 Valvular heart disease
 Exercise-induced bronchoconstriction
ARVC indicates arrhythmogenic right ventricular dysplasia/cardiomyopathy; AV, atrioventricular; CBC, complete blood count; CT, computed tomography; DCM, dilated cardiomy-
opathy; HCM, hypertrophic cardiomyopathy; LVNC, left ventricular non-compaction cardiomyopathy; MRI, magnetic resonance imaging; RCM, restrictive cardiomyopathy; and TSH,
thyroid stimulating hormone.
Lawless et al. J A C C V O L . 6 4 , N O . 2 0 , 2 0 1 4
Protecting the Heart of the American Athlete N O V E M B E R 1 8 / 2 5 , 2 0 1 4 : 2 1 4 6 – 7 1
2152Premature ventricular contractions (PVCs) are common
in athletes, but for unclear reasons. Limited data suggest
that PVCs $2,000/24 hours are associated with a higher
chance of underlying heart disease (62). Whether this is
due to the PVC burden alone (63) or to true underlying
structural disease is not known. If no underlying heart
disease is present, RTP without restrictions with PVCs is
generally safe.
Dyspnea
Dyspnea in the athlete is a common complaint, with a
differential that spans a wide range of benign and serious
causes (64). Assessment of dyspnea should begin with an
attempt to characterize the nature and severity of the
symptom: whether it is associated with a decrease in ex-
ercise capacity; episodic or predictable; severe relative to
other athletes; related to changes in air temperature orhumidity; occurring in the setting of wheezing; associated
with rapid or slow heart rate; and whether the athlete has
known cardiac and/or pulmonary abnormalities or is an
older person with coronary artery disease (CAD) risk fac-
tors. After assessment of dyspnea, cardiac assessment
should be performed, with ECG and echocardiography. If
the athlete has a known history of cardiac disease and
complaints of dyspnea, the baseline abnormality should
be reassessed. Differential diagnosis of cardiac causes of
dyspnea, and suggested work ups are listed in Table 3.
Pulmonary causes of dyspnea can be explored using
pulmonary function tests at rest and, if necessary, in a
setting similar to that which causes the symptoms (e.g.,
peak ﬂow measures on the soccer or track ﬁeld). Exercise-
induced asthma is the most common cause of dyspnea in
athletes (65). Asthma and vocal cord dysfunction may
coexist in a given athlete (66).
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2153New dyspnea complaints at similar exercise levels or
complaints occurring at lower activity levels in an older
athlete should lead to consideration of ischemic heart
disease. Dyspnea relative to other athletes, once evalu-
ated for cardiac and pulmonary causes, may be due to
hormonal or metabolic causes or to lack of conditioning
relative to peers. Cardiopulmonary exercise testing with
gas exchange and ventilatory parameters is potentially
helpful in documenting true functional capacity relative
to appropriate age and ﬁtness status.
Fatigue
Fatigue (and/or unsatisfactory athletic performance) is a
common and yet nonspeciﬁc complaint; work ups in
athletes can be as frustrating as workups in non-athletic
populations. A balance between adequate caloric intake
to maintain performance on the one hand, and obtaining
and maintaining appropriate body composition on the
other hand, is essential to maximize performance and
avoid “overtraining” and fatigue (67). When fatigue is the
only symptom, a cardiac diagnosis is exceedingly rare.
This impression is based on experience, rather than
known published data.
Screening of Those with Positive Family History
The majority of SCA/SCD-associated conditions in
athletes #35 years have a genetic basis (11,16). Unfortu-
nately, most people are not fully aware of important
aspects of their family history, making screening a
relatively unhelpful tool. About 16% of those with a prior
SCA/SCD have a known positive family history (FHx) (47).
Efforts to heighten awareness of FHx should includeTABLE 4 Pitfalls in Interpreting Cardiac Testing in Athletes
Test
Stress test 1. Bruce protocol is designed to detect co
2. Testing protocol needs to simulate con
3. Some providers are not aware of this.
ECG 1. Lack of normative data in all groups of
2. Can European data be extrapolated to
3. Heterogeneity of athlete groups: one s
4. Does not detect anomalous coronary ar
Echocardiography 1. Lack of normative data in all groups of
2. Can European data be extrapolated to
3. Heterogeneity of athlete groups: one s
4. Sensitivity for detection of anomalous
Ambulatory monitoring 1. Routine monitoring may not detect the
2. Challenges to monitoring: contact spor
3. Depending on when symptoms occur, t
4. Lacking normative data in large numbe
MRI 1. Lack of normative data in all groups of
2. What does ﬁbrosis mean?
CT 1. Lack of normative data in all groups of
2. How can risk of radiation be minimized
3. Ratio of risk:beneﬁts of MRI versus CT
CT indicates computed tomography; MRI, magnetic resonance imaging; SCA, sudden cardiacdevelopment of a workable deﬁnition of positive FHx,
promotion that FHx be part of a general health evaluation,
and instruction for patients on ﬁlling out a simple
family tree. The AHA documents and the 4th PPE are
not completely congruent regarding the deﬁnition of
FHx (16,60).
General Considerations for Ordering and Interpreting
Diagnostic Tests in Athletes
Diagnostic testing in the athlete is affected by a number
of issues peculiar to the population (Table 4). These is-
sues have been outlined in detail in a recent publication
(14). For example, “normal” values for a given athlete
may lie outside the published “non-athlete” norm (11,68).
Additionally, stress testing and ambulatory monitoring
require tailoring to simulate the demands of the indi-
vidual athlete’s sport. Athlete safety must be balanced
against the risk of inappropriate testing, unnecessary
exercise restriction, over-diagnosis, and inappropriate
procedures. The availability of an athlete-centered
knowledge base to interpret test results for athletes
may help to limit the “diagnostic creep” whereby one
slightly abnormal test leads to another slightly abnormal
test and so on. Additionally, in the long term, testing and
treatment may have a more adverse impact on an ath-
lete’s physical and psychological health than continued
participation.
RTP Decision Making in the Athlete
The 36th Bethesda Conference outlined sports participa-
tion recommendations for speciﬁc cardiovascular con-
ditions (15), but it has been criticized owing to itsGaps
ronary artery disease, not inherited diseases.
ditions and demands of sport.
American athletes.
American athletes?
ize of normative data does not ﬁt all.
tery, second most common cardiac cause of SCA/SCD in athletes.
American athletes.
American athletes?
ize of normative data does not ﬁt all.
coronary artery may vary according to athlete body habitus.
problem.
ts, lead adherence under certain conditions, underwater sports
hey may need to be monitored while the athlete is practicing or competing.
rs of American athletes at all levels: how much ectopy is “normal”?
American athletes
American athletes
?
in athletic populations is not clearly deﬁned.
arrest; and SCD, sudden cardiac death.
TABLE 5 Guidelines for Sports Participation for Athletes With Known Cardiac Conditions
Guideline Comment
AHA 2007 Update  12 elements are “embedded” in PPE
 Does not recommend routine ECG screening
36th Bethesda Conference recommendations  Gold standard for RTP in USA
 Classiﬁes sports by dynamic and static components
ESC Participation Recommendations  Similar to Bethesda’s but with notable differences
 No participation for genotype positive–phenotype negative HCM
AHA Consensus for Young Patients with Genetic CVD  Includes grading system for exercise
 Consistent with Bethesda’s
 Useful for prescribing exercise for those with high risk conditions
NASPE Policy Conference on Arrhythmias and the Athlete  Older but similar to Bethesda’s
WHF, IFSM, AHA Consensus on Masters Athletes  Similar to Bethesda’s
 Athletes >40 years of age
 Range of conditioning from elite athletes to walk-up athletes
AHA indicates American Heart Association; ECG, electrocardiogram; ESC, European Society of Cardiology; HCM, hypertrophic cardiomyopathy; IFSM, International Federation for Sports
Medicine; NASPE, North American Society for Pacing and Electrophysiology (now Heart Rhythm Society); PPE, pre-participation evaluation; RTP, return to play; and WHF, World Heart
Federation. (Adapted from Oliveira [72].)
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2154dependence on expert opinion rather than high-quality
evidence (69,70). Two recent reports in athletes with
implantable cardioverter deﬁbrillators and in patients
with long QT syndrome are illustrative of the type of data
that needs to be generated to help elevate this expert
opinion to the status of true guidelines (70,71). A strategy
devised for a particular athlete, although potentially
based on sound published data or even consensus “expert
opinion,” is complicated by knowledge gaps, medical
legal issues, and mutual athlete/family input. The same
holds true for all of the other main published athlete
participation guidelines (Table 5) (72).SECTION 3. PRIMARY AND SECONDARY
PREVENTION OF SCA/SCD EPISODES
IN ATHLETES
Primary Prevention
Primary prevention of SCA/SCD requires identiﬁcation
of a predisposing disease, and early intervention to miti-
gate risk. The optimal screening protocol facilitates
diagnosis of individuals at risk for SCA, enables effective
identiﬁcation, and recommends optimal therapy strate-
gies to improve survival without causing harm. This re-
mains a matter of discussion related to the knowledge
gaps that could guide this comprehensive goal (25).
Screening Methods and Standards in the United States
The current American Heart Association- (AHA) recom-
mended cardiovascular screening protocol for competi-
tive athletes uses a history and a physical exam-based
PPE that includes 12 AHA elements (Table 6) (16). All 12
elements are incorporated into the most recent PPE
monograph (4th PPE, 60), a collaborative effort of 6 na-
tional medical societies that recommends a PPE by theathlete’s personal physician upon entry into sports at the
high school and college levels. Mass PPE Screening (e.g.,
in the high school gymnasium) is highly discouraged
(60,73). State legislatures, state interscholastic athletic
associations, or departments of education may set speciﬁc
standards and some local school districts or schools will
direct their speciﬁc standards.
Compliance with the AHA recommendations is poor at
the state, physician, and athletic department levels (73).
The latest account found that only about 5% of states
use all 12 AHA elements in their forms (74), and only 8
states utilize a form consistent with the PPE Monograph
(73). Non-physician personnel such as chiropractors are
currently allowed to perform PPEs in 35% of states (74).
Standardization of the PPE should improve this model
(16). Future efforts must address provider education and
policy requirements to improve implementation of the
most recent recommendations from leading national
medical societies.
Outcome data for the standardized PPE in American
athletes is limited. Insurance data from the Minnesota
State High School League, where a comprehensive stan-
dardized PPE is performed, indicates that the death rates
during competitive sports appear to be exceedingly low
(0.24 per 100,000 ) in high school student-athletes over a
19-year period (75). Other analyses of Minnesota high
school age athletes (that include all deaths in athletes in
this age group) show a death rate of 0.7 per 100,000
athletes (76,77). These data appear to support that careful
evaluation of high school athletes may identify some with
cardiovascular warning symptoms or signs. At present,
30% to 47% of National Collegiate Athletics Association
Division I programs and 14% of lower-division programs
use non-invasive cardiovascular screening methods (ECG
and/or echocardiogram) for either all athletes or those
deemed to be high risk (78,79).
TABLE 6
The 12-Element AHA Recommendations
for Preparticipation Cardiovascular
Screening of Competitive Athletes
Medical history*
Personal history
1. Exertional chest pain/discomfort
2. Unexplained syncope/near-syncope†
3. Excessive exertional and unexplained dyspnea/fatigue,
associated With exercise
4. Prior recognition of a heart murmur
5. Elevated systemic blood pressure
Family history
6. Premature death (sudden and unexpected, or otherwise) before age 50 years
due to heart disease, in $1 relative
7. Disability from heart disease in a close relative #50 years of age
8. Speciﬁc knowledge of certain cardiac conditions in family members:
hypertrophic or dilated cardiomyopathy, Long QT syndrome or other ion
channelopathies, Marfan syndrome, or clinically important arrhythmias
Physical examination
9. Heart murmur‡
10. Femoral pulses to exclude aortic coarctation
11. Physical stigmata of Marfan syndrome
12. Brachial artery blood pressure (sitting position)§
*Parental veriﬁcation is recommended for high school and middle school athletes.
†Judged not to be neurocardiogenic (vasovagal); of particular concern when related to
exertion. ‡Auscultation should be performed in both supine and standing positions
(or with Valsalva maneuver), speciﬁcally to identify murmurs of dynamic left ventricular
outﬂow tract obstruction. §Preferably taken in both arms. Reproduced with permission
from Maron et al. (16).
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2155Other Screening Methods—ECG Screening
Data from the Italian screening program suggest that ECG-
based screening may prevent SCD by identifying youth
with undiagnosed conditions predisposing them to SCA,
although those excluded from activity were not tracked
for outcomes data (80). The incidence of SCD in athletes
decreased from 3.5 to 0.4 per 100,000 athletes (89%) over
a 25-year period. The death rate at the start of the program
was high, perhaps because of the lack of appreciation of
arrhythmogenic right ventricular dysplasia (ARVC), which
is common in this part of Italy (81). In contrast, Israel has
implemented a mandatory ECG screening program but
has not reported a reduction in SCD (82). Adding an ECG
to the history and physical may increase disease detection
sensitivity relative to history and physical alone (83–86),
but large-scale U.S. data are lacking to determine if
this approach will prevent SCD, or do more harm than
good compared with the currently recommended AHA
standard (16). Similarly, data are lacking to show the
overall effectiveness of the history and physical in iden-
tifying a majority of individuals at risk for a SCA or pre-
venting SCD. Advanced imaging modalities for screening,
such as echocardiography, may increase the sensitivity to
detect a small proportion of cardiac diseases. But these
modalities come with economic and logistical costs and
may even provide false reassurance, especially if “limited
echocardiography” is done only to exclude hypertrophic
cardiomyopathy. ECG and echocardiography are useful
during secondary evaluations to assess for electricalconditions, cardiomyopathy, valvular disease, or coro-
nary anomalies, and are essential for a thorough evalua-
tion of a symptomatic athlete.
Suggested barriers to ECG screening in the United
States have traditionally included high false positive
rates, false negatives, feasibility, logistics, costs, efﬁcacy,
risks of inappropriate exclusion from sports, potential
anxiety associated with testing, unnecessary procedures
performed either to evaluate or treat potential or
asymptomatic disease, future insurability, and the risk of
treatments (16).
Athlete-speciﬁc ECG interpretation criteria have the
potential to decrease false positive rates and improve
cost-effectiveness (87–89). Determining ECG parameters
in youth according to age, gender, race and ethnicity, and
sport type and intensity should improve ECG test char-
acteristics and make some types of false positives less
common (90). Recommendations of ECG criteria to
improve sensitivity and speciﬁcity await validation by
clinical trials (91–93). The best methods to identify those
athletes at risk for SCA through primary screening are
controversial, with ongoing debate regarding the addition
of an ECG (12,13,94–102). Before changes in screening
programs are recommended nationally, data should be
acquired that can demonstrate an improved outcome in
young, asymptomatic athletes and show that the beneﬁt
of screening outweighs the risks. The dilemma of dispo-
sition of the asymptomatic athlete with a condition
associated with SCD also remains a key concern in this
debate, regardless of how such athletes are identiﬁed.
Secondary Prevention
Because screening will neither detect all at risk nor
prevent commotio cordis, SCA/SCD will continue to
occur in sports. Secondary prevention of SCD requires
life-saving measures when an SCA occurs. AEDs alone
will not solve the problem. Coaches, staff, athletes, and
bystanders should be taught to recognize SCD, perform
cardiopulmonary resuscitation (CPR), and operate an AED
as part of a comprehensive Emergency Action Plan (EAP).
Overview of Chain of Survival and Public Access Deﬁbrillation
Community studies have demonstrated that public access
deﬁbrillation programs are effective in sites of high pop-
ulation density where emergency medical services (EMS)
response may be slow, producing high survival rates in
multiple venues (103–107).
Recognition of SCA
The AHA has stated that the sudden collapse of an adult
should cause suspicion of a SCA (108). In healthy athletes,
onemay not have as strong a suspicion of a SCA. Thus there
is less expectation of SCA, with delays in recognition.
Seizure-like activity occurs in 30% to 40% of SCAs owing
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2156to brain anoxia, and agonal gasping respirations occur in
30% to 40%, adding to the hesitancy of a bystander to
suspect SCA and act. Any collapse, even following trauma,
should be considered a SCA; 911 should be called, CPR
initiated, and an AED, if present, should be used with as
little interruption to CPR as possible (109,110).
Areas that Determine Impact of Resuscitation
The interval between cardiac arrest and initiation of CPR
is one of the prime determinants of the time to deﬁbril-
lation and of survival, with survival unlikely for time in-
tervals greater than 10 minutes to deﬁbrillation (106).
Advanced life support in the ﬁeld increases the likelihood
of survival in cardiac arrest, and hospital care with
induced hypothermia dramatically improves prognosis
(111). The new AHA guidelines support the delivery of
high-quality chest compressions with minimal in-
terruptions for both hands-only and conventional CPR.
Factors including quality, depth, rate of compressions,
and duration of interruptions impact the outcome of the
cardiac arrest (112).
Effectiveness of AED Programs
High School Athletics
SCA in young athletes is a catastrophic event with a his-
torically low survival rate (4% to 21%) (113–115). Data from
486 cases of exercise-related SCA in young individuals
show an average survival rate of just 11% from 2000 to
2006 (113). A similar survival rate of 16% was found in 128
cases from the USA Commotio Cordis Registry (116). These
results are attributable to delayed rescuer recognition of
SCA, slow response times, and inadequate preparation.
Early CPR and deﬁbrillation with an AED in youth can
result in a survival rate of 64% to 74% (117). A 2-year
prospective study in 2,149 high schools indicated that
87% of participating schools had an onsite AED program,
with 89% of students and adults who developed SCA
during sports or physical activity at schools with an onsite
program surviving to hospital discharge (118). The sur-
vival rate for commotio cordis in young athletes has
increased to 58% in the last 6 years, largely because of
increased recognition, greater availability of AEDs, and
early deﬁbrillation (119). Early deﬁbrillation and onsite
AED programs are therefore both critical and effective in
maximizing survival following SCA in the athletic setting.
Intercollegiate Sports
Detailed reports of resuscitation outcomes for National
Collegiate Athletic Association athletes demonstrate
dismal survival rates. A report of National Collegiate
Athletic Association programs found that 91% of
Division I, 77% of Division II, and 81% of Division III
institutions had at least one AED on site (120,121).
Although an encouraging development, a comprehensiveemergency action plan (EAP) should include more than
onsite AEDs alone.
SCA at Schools and Athletic Events
Emergency planning and AEDs at schools and sporting
venues offer the potential for effective secondary pre-
vention of SCD. SCAs reported in schools occur primarily
in adults, with only 34% occurring in children. Most were
witnessed (83%) and received bystander CPR (77%).
Ventricular ﬁbrillation was the initial rhythm in 57% of
patients, and 32% survived to hospital discharge (122).
The frequency of SCA in adults >35 years has been re-
ported at 1:1,000, suggesting that emergency preparations
should extend beyond athlete participants (123,124).
Keys to Successful Resuscitation
Emergency Action Plans
The ability to respond to SCA depends heavily on prepa-
ration and a coordinated effort on the part of all re-
sponders. In 2004, the AHA recommended that all schools
have an emergency action plan (110,125). The 2007 Inter-
Association Task Force provided consensus recommen-
dations for the management of SCA in the athletic setting,
which include the need for schools to have onsite AEDs if
they cannot reliably achieve an EMS call-to-shock interval
of less than 5 minutes (17). Elements of an effective
AED program include: 1) development of an effective
communication system to alert onsite responders and
activate the local EMS system; 2) coordination of the
response plan among school, team, or club staff and local
EMS; 3) instruction and training of potential ﬁrst re-
sponders in CPR and AED use; 4) rapid availability of AEDs;
and 5) practice and review of the EAP at least annually (125).
Steps also should be taken to ensure appropriate device
maintenance and readiness checks before sporting events.
The EAP should be developed and coordinated with local
EMS personnel, school public safety ofﬁcials, on-site ﬁrst
responders, and school administrators, and reviewed with
certiﬁed athletic trainers, team and attending physicians,
athletic training students, school and institutional safety
personnel, and coaches. EAPs should be speciﬁc to each
individual athletic venue. The ﬁrst responder may be a
coach, strength and conditioning staff, or other institu-
tional personnel. Involving student athletes in the EAP
may improve the potential for a successful outcome,
particularly if the coach is the victim.
Location of AEDs and Training of School and Athletic Staff
AEDs should be readily available and on site at the athletic
venue when emergency situations arise, ensuring no more
than a 2- to 3-minute turnaround from the site of potential
collapse. Schools should ensure that away competitions
have protection or bring a spare AED. Certiﬁcation in CPR,
AED, and EAP review should be required for all athletic
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instruction, and strength and conditioning.
Funding for School/Athletic Field AEDs
Many funding sources are available, including donations
by community organizations, foundations, hospitals, and
individuals who have lost a family member. Once ob-
tained, responder training, maintenance of pads, and
replacement and maintenance of batteries results in
additional operational costs.
AEDs in Schools
It has been estimated that on any given school day, 20%
of the population will be in a school, including many adult
employees, visitors and those using schools for commu-
nity events, including adult education and voting.
In 2004, guidelines for treating SCA in schools sug-
gested that a lay rescuer AED implementation program be
considered in any location (e.g. school) with at least one
of the following: 1) a reasonable probability of AED use
within 5 years after AED placement and training of lay
rescuers; 2) high-risk adults working at the school or
children attending school who might be at risk for a SCA;
and 3) the inability to reliably achieve a EMS call-to-shock
interval of <5 minutes (110). The AHA supports state
legislation and education policies and encourages each
high school to have an AED and to appropriately train
personnel, including athletic coaches, trainers and ath-
letes (110). Between 30% and 70% of schools are noted to
have AEDs, some donated or purchased with funds raised
by parents or from foundations of parents who have lost
children to SCA and many purchased at a discount with
industry support (123,126–128).
Effective adoption of AEDs in schools involves the
following: 1) Creation of an EAP that includes early CPR
and AED; 2) Creation of an AED team in the school; 3)
Integrating CPR training into the school curriculum and
insuring that adequate numbers of teachers, students,
administrators, and staff (including coaches, nurses, and
other athletic staff) are trained in CPR and AED skills; 4)
Acquiring adequate numbers of AEDs for school and
athletic events, both at home and away; and 5) Consid-
eration of access to an AED within 3 to 5 minutes. The
major barriers to AED acquisition in schools include cost
of purchase, cost of maintenance, and lack of time for
training (129).
Student CPR/AED Education and Training
In 2003, the International Liaison Committee on Resus-
citation recommended that CPR education be part of the
school curriculum (129). In 2004, the AHA recommended
training all teachers and students in CPR. In 2011, the AHA
issued an AHA Science Advisory recommending that
training in CPR and familiarization with AEDs be requiredelements of secondary school curricula, with guidelines
for overcoming barriers (130).
A number of studies support the feasibility and efﬁcacy
of teaching CPR and AED use to school children. Such
training should emphasize the recognition of SCA, the
importance of calling for help or for an AED, and the
delivery of high-quality chest compressions. Studies in
subjects aged 4 to 20 years indicate the improvements
that occur with training. Those provided instruction in
practical, hands-on skills exhibit better performance skills
than do those with instructional or theoretical knowledge
alone. Chest compression depth correlates with physical
factors such as weight and height, with studies showing
that 14 year olds can perform these skills as well as can
adults (131). With minimal training, 9 to 12 year olds have
been shown to accurately use an AED in a time frame just
slightly shorter than that expected of trained emergency
medical technicians. Training by school teachers has been
shown to be as effective as that performed by healthcare
professionals. The most effective retention training has
not been determined, but full instructor-led courses are
not more effective than self-instruction and computer-
based models.
In King County, WA, 52% of bystanders can perform
CPR; the area’s survival rate is higher than that of the rest
of the United States (132). In Norway, the training of over
50,000 school children was associated with an increase in
bystander CPR from 60% to 73% (133). Students with
training have been shown to be more willing to perform
CPR (132).
Barriers to CPR training in schools have been noted to
include a lack of trained instructors, lack of time in the
school curriculum, and lack of funding (132). Personal
barriers noted by students that affect their willingness to
use CPR or AED skills include concerns related to both
poor knowledge and fear of imperfect performance
(130,134). Simpliﬁcation of the process by recommenda-
tion of hands-only bystander CPR may increase by-
standers’ willingness to use their skills.
Legal Implications of Secondary Prevention
CPR legislation has advanced rapidly since the passage of
the Sudden Cardiac Arrest Act in 2000. Multiple variations
of these laws exist (see Table 7).
SECTION 4. AN ACTION PLAN FOR PROTECTING
THE HEART OF THE AMERICAN ATHLETE
(TABLES 8–12)
Stakeholders
Our goal was to bring together a group of many relevant,
diverse stakeholders to develop collaborative, multidis-
ciplinary approaches to improving the cardiovascular care
of American athletes of all ages. This ambitious goal
TABLE 7 Legal Implications of Secondary Prevention
Law or policy Implication
Good Samaritan laws All states in the US have some type of “Good Samaritan” legislative protection that protects bystanders from legal liability if AED use
is attempted without “gross negligence or willful and wanton misconduct.” Legal protections for owner-leaders or medical
personnel are less straightforward.
CPR curricula As of the 2009-2010 school year, content standards for CPR curricula are present in 36 states. These standards vary from recognizing
the steps of CPR to full certiﬁcation.
AED laws As of 2012, 15 states had legislative mandates requiring or supporting AED placement in schools. All 50 states plus the District of
Columbia have at least 1 piece of AED legislation in place.
The Josh Miller Act The Josh Miller Act was introduced in Congress in April 2011 to establish a grant program for AEDs in elementary and secondary
schools. It was referred to committee but not acted upon.
AED indicates automated external deﬁbrillator and CPR, cardiopulmonary resuscitation.
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perspective, activities, and experiences of each group.
Front-line providers—athletic trainers, school nurses,
team/sports physicians, and physicians who provide
coverage for events: As the inpatient care team is to
hospitalized patients, these front-line providers are to
relatively healthy, out-patient competitive athletes.
Serving athletes at the front lines at practices and com-
petitions, these providers are responsible for the imme-
diate care, including AED application, of an athlete who
develops symptoms (e.g., collapse, SCA). They make im-
mediate RTP decisions and are responsible for creating
and implementing all athlete healthcare policies both at
local and national levels through their professional soci-
eties and sports governing bodies. These providers belong
to or work closely with the American Academy of Family
Physicians (AAFP), American Academy of Pediatrics
(AAP), American College of Sports Medicine (ACSM),TABLE 8 Quantifying Risks to American Athletes
Gap(s) Strategies and Metho
True cardiac risks to athletes are unknown
owing to varying methodologies, incomplete
assessment of risk, overlap with other causes
of sudden death, and balancing risk of
participation with the risk of not
participating.
Deﬁne sports cardiology metrics
1. Convene multidisciplinary group
create well-deﬁned metrics for
incidence of SCA/SCD in athlet
major outcomes.
2. Resolve disparate deﬁnitions of
and denominator in SCA/SCD r
and recommend how rates be
literature.
3. Resolve controversies over whe
are exercise related or athlete
4. Arrive at consensus on other sig
and sports cardiology outcome
arrhythmias, days missing com
practice dissection, ﬁbrosis).
Conduct epidemiologic research
5. Once metrics are deﬁned, devel
prospective athlete outcomes r
are sports speciﬁc and level spe
into account athlete heterogen
6. Include risks of cardiac testing/t
procedures in athlete registries
7. Include risks of sedentary lifesty
AAFP indicates American Academy of Family Physicians; AANP indicates American Association
of Physician Assistants; ACC, American College of Cardiology; ACP, American College of Phy
AMSSM, American Medical Society for Sports Medicine; AOASM, American Osteopathic Acade
cardiovascular; MI, myocardial infarction; NATA, National Athletic Trainers Association; SCA,American Medical Society of Sports Medicine (AMSSM),
American Orthopaedic Society for Sports Medicine
(AOSSM), National Athletic Trainers Association (NATA),
National Collegiate Athletic Association (NCAA), National
Federation of State High School Associations, professional
sports leagues (e.g., Major League Baseball, Major League
Soccer, the National Football League, the National Hockey
League, the National Basketball League), and the United
States Olympic Committee and its collection of “sportfo-
lios” of U.S. sports federations (e.g., U.S. Figure Skating,
U.S.A. Track and Field).
Other healthcare providers and their respective profes-
sional and scientiﬁc organizations: Primary care pro-
viders (e.g., family practitioners, pediatricians, sports
medicine and/or team physicians, nurse practitioners,
physician assistants, cardiac care associates, cardiolo-
gists, cardiovascular subspecialists) screen and/or eval-
uate athletes of all ages, request and/or provide andds Responsible Parties Time Frame
of experts to
causes and
es, and other
numerator
ate equation,
reported in
ther events
centered.
niﬁcant CV
s (e.g., MI,
petition or
Healthcare providers and their respective
professional and scientiﬁc organizations:
AAFP, AANP, AAP, AAPA, ACC, ACP, ACSM,
AHA, AMSSM, AOASM, AOSSM, NATA;
research scientists; funding agencies
2014-2015
op
egistries that
ciﬁc and take
eity.
reatment and
.
le.
Same as above Ongoing
of Nurse Practitioners; AAP, American Academy of Pediatrics; AAPA, American Academy
sicians; ACSM, American College of Sports Medicine; AHA, American Heart Association;
my for Sports Medicine; AOSSM, American Orthopaedic Society for Sports Medicine; CV,
sudden cardiac arrest; and SCD, sudden cardiac death.
TABLE 9 Education, and Optimal Use of Existing Clinical Athlete Care Tools
Gap(s)
Strategies and
Methods Responsible Parties Time Frame
Gaps in provider knowledge about
athletes and about conditions
that place them at risk
Optimal implementation of existing
clinical tools.
1. Education and/or certiﬁcation of providers
making participation decisions (at all levels)
2. Education includes knowledge use of the 4th
PPE, 12 AHA elements, 36th Bethesda
Conference guidelines, and masters
athletes.
3. Enhance presence of tools on AAFP, AANP,
AAP, AAPA, ACC, ACP, ACSM, AHA, AMSSM,
AOASM, AOSSM, and NATA Web sites.
4. Monitor knowledge and use of tools
through performance improvement
activities and CME.
Healthcare provider professional and scientiﬁc
organizations: AAFP, AANP, AAP, AAPA,
ACC, ACP, ACSM, AHA, AMSSM, AOASM,
AOSSM, NATA; school nurses, athletic
directors, and coaching staff
2014-2016
Develop core competencies in sports and
exercise cardiology (athlete-centered
CV care).
1. Create competencies for all those involved in
athlete CV care, appropriate to type of
practice, in collaboration with respective
professional societies and board examiners:
AAFP, AANP, AAP, AAPA, ACC, ACP, ACSM,
AHA, AMSSM, AOASM, AOSSM, NATA,
school nurses, athletic directors, and
coaching staff.
2. Include basic sports cardiology competencies
in general certiﬁcation exams.
3. Update competencies as new information
becomes available.
4. Promote development of team-based care at
local levels (ATC, team physician, school
nurses, PCPs, cardiologist and cardiac
subspecialists).
Same as above 2014-2017
Gaps in provider knowledge of risk
mitigation strategies: hands-only CPR,
recognition of SCA and its warning signs,
and optimal implementation of AEDs in
schools and athletic venues
Educate on early identiﬁcation of SCA, including
seizures and agonal breathing.
1. Focus education on those likely to respond
ﬁrst to a collapse: ATCs, school nurses, team
physicians, coaches, parents, students, and
teachers.
2. Incorporate identiﬁcation of SCA/SCD into
general proﬁciency examinations for
providers and ﬁrst responders.
Front-line providers: ATCs, school nurses,
team/sports physicians, and physicians
who provide coverage for events; athletic
directors, and coaching staff; athletes;
educators; parents; public; and media
2014-onward
Educate on SCA warning signs and symptoms
while not unnecessarily restricting athletes.
1. Focus education on those likely to respond
ﬁrst to a collapse: ATCs, school nurses,
coaches, parents, students, and teachers.
2. Create a multidisciplinary educational tool-kit
at the national level that can be used by all
50 states to educate.
Same as above plus: healthcare provider
professional and scientiﬁc organizations:
AAFP, AANP, AAP, AAPA, ACC, ACP, ACSM,
AHA, AMSSM, AOASM, AOSSM, NATA
2014-onward
Promote widespread knowledge of hands-only
bystander CPR.
1. Convene a state-wide multidisciplinary task
force to work with state DHHS and board
of education to promote CPR training in
required curricula for all middle school and
HS students (see advocacy).
2. Create public service announcements at
sporting events to promote hands-only
CPR and early application of AED.
Same as above 2014-onward
Enhance AED efforts in each state
(see Advocacy).
Same as above Ongoing
AAFP indicates American Academy of Family Physicians; AANP, American Association of Nurse Practitioners; AAP, American Academy of Pediatrics; AAPA, American Academy of
Physician Assistants; ACC, American College of Cardiology; ACP, American College of Physicians; ACSM, American College of Sports Medicine; AHA, American Heart Association;
AMSSM, American Medical Society for Sports Medicine; AOASM, American Osteopathic Academy for Sports Medicine; AOSSM, American Orthopaedic Society for Sports Medicine; ATC,
Certiﬁed Athletic Trainer; CME, continuing medical education; CPR, cardiopulmonary resuscitation; CV, cardiovascular; MI, myocardial infarction; NATA, National Athletic Trainers
Association; PCP, primary care provider; SCA, sudden cardiac arrest; and SCD, sudden cardiac death.
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TABLE 10 Research, Quality, and Science
Gap(s) Strategies and Methods Responsible Parties Time Frame
Predictive value of symptoms not known Develop evidence-based symptom
management.
1. Promote and conduct research examining
the predictive value of symptoms in
athletes (level and sports speciﬁc).
2. Align data among disparate groups.
3. Develop data-driven management
algorithms.
Healthcare providers and their respective
professional and scientiﬁc organizations;
research scientists; funding agencies
2014-onward
Lack of normative data in large populations
of American athletes of varying age, race,
ethnicity, size, and sport
Deﬁne norms in American athletes
1. Review European data and determine
if applicable to USA.
2. Deﬁne gaps for norms in American athletes
for ECG, echocardiography, MRI, CT,
ambulatory monitoring, and stress testing.
3. Close knowledge gaps through researching
large numbers of American athletes (level
and sports speciﬁc).
4. Align data among disparate groups.
5. Develop data-driven management
algorithms.
Same as above 2014-onward
Lack of an evidence base in traditional
participation guidelines
Establish sports participation registries in those
with disease.
1. Use data to raise level of evidence for
Bethesda guidelines.
2. Use practice-based registries to tell us
“how we are doing.”
3. Align data among disparate groups.
4. Develop data-driven management
algorithms
Same as above 2014-onward
Gaps in ECG screening debate Raise quality of ECG algorithms and validate
prospectively
1. Convene multidisciplinary group of experts to
deﬁne how interpretation algorithms should
be derived and developed.
2. Encourage the derivation of algorithms on
the basis of knowledge of underlying
structure (echo or MRI).
3. Validate algorithms prospectively in
clinical trials.
Same as above 2014-2017
Efﬁcacy
1. Encourage randomized controlled trials
with well-deﬁned outcomes.
2. Determine if identiﬁcation of an underlying
high-risk condition qualiﬁes as a surrogate
outcome (see Table 1—Metrics).
Same as above 2014-onward
CT indicates computed tomography; ECG, electrocardiogram; and MRI, magnetic resonance imaging.
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immediate and long-term RTP decisions that have the
potential to ensure optimum safety for the athlete.
Although their role in many cardiovascular facilities has
been limited to performance of stress testing, exercise
physiologists’ knowledge base is invaluable for the
cardiovascular care of athletes.
Some of these providers may be directly responsible
for athlete cardiovascular care on the front lines,
although it is more likely that they will provide care off
the playing or practice ﬁeld. In addition, they are
responsible for deﬁning the content of undergraduate,
graduate, and continuing medical education, and devel-
oping standards of care. Non-physician staff members are
also critical to developing and implementing standards.
These providers belong to or work closely with the AAFP,AAP, ACC, American College of Sports Medicine (ACSM),
American Heart Association (AHA), AMSSM, AOASM,
American Society of Echocardiography, Association of
Black Cardiologists, Children’s Cardiomyopathy Founda-
tion, Heart Rhythm Society, Society for Cardiovascular
Magnetic Resonance, and Hypertrophic Cardiomyopathy
Association.
Research scientists and funding agencies: Epidemiolo-
gists, exercise scientists, and academic clinicians working
in both the basic and clinical sciences perform much-
needed research about the risks and beneﬁts of exercise,
the adaptation of the cardiovascular system to training,
and the interaction of the heart and vasculature with the
internal and external athletic environments. They are
supported by funding agencies and health policy makers,
and belong to or work closely with the Centers for Disease
TABLE 11 Potential Research Directions: Sports and Exercise Cardiology
1. Epidemiology of cardiac events in athletes
a. Detect the true prevalence and clinical relevance of heart diseases in athletes.
b. Identify individuals at highest risk.
c. Develop standardized outcomes metrics for fatal and non-fatal events.
d. Determine the true rates of SCD and SCA in well-deﬁned athletic populations.
2. Evaluation
a. Determine the predictive value of symptoms.
b. Deﬁne normative data and reference values for ECG, echocardiography, and cardiac MRI in multi-racial and multi-ethnic American athletes at different
levels (high school through Masters).
c. Characterize chamber remodeling in all ages and levels of athletes.
d. Correlate symptoms with underlying structure.
e. Correlate surface ECG with underlying structure.
f. Elucidate why some athletes remodel and others do not, even among homogeneous athletic populations.
g. Prospectively validate cardiac testing in athletes.
h. Deﬁne which cardiac tests (e.g., ambulatory monitoring, stress protocols) produce the greatest and most cost-effective diagnostic yield.
i. Conduct randomized trials of PPE alone versus PPE plus ECG in varying demographic groups.
3. Management
a. Determine the efﬁcacy of deﬁbrillation (AEDs and ICDs).
b. Create a data-driven approach to differentiating pathology from athletic adaptation with regard to:
i. Cardiomyopathies;
ii. Aortic dimension, pulmonary pressure, and valvular regurgitation; and
iii. Long QT, Brugada, and early repolarization.
c. Specify the best treatments for asymptomatic WPW and atrial ﬁbrillation.
d. Identify the best way to diagnose and treat anomalous coronary artery and determine which variants require treatment.
e. Correlate changes seen in endurance athletes with long-term outcomes.
f. Determine risk and/or safe levels of exercise in individuals with heart disease to allow for revision of participation guidelines.
AED indicates automated external deﬁbrillator; ECG, electrocardiogram; ICD, implantable cardioverter deﬁbrillator; MRI, magnetic resonance imaging; PPE, pre-participation
evaluation; SCA, sudden cardiac arrest; SCD, sudden cardiac death; and WPW, Wolff-Parkinson-White. (From Lawless, 14)
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Institute; AHA; and other funding organizations.
Sports governing bodies: National sports governing
bodies, including professional leagues (e.g., Major League
Baseball, Major League Soccer, the National Basketball
Association, the National Football League, the National
Hockey League), the U.S. Olympic Committee, National
Collegiate Athletic Association, National Federation of
High Schools (NFHS), and state sports commissions,
are responsible for creating policies regarding care that
promote athlete safety, ensuring compliance, and res-
ponding to proposed changes in athlete screening pro-
tocols that would aim to minimize risk and optimize
safety. Other groups, such as the ACC, AAP, AAFP, ACSM,
AHA, AMSSM, and National Athletic Trainers Association,
can promote safety and standardization through educa-
tion and accreditation of providers in athlete cardiovas-
cular care and establishment of standards of care.
Payers: The payer environment for athletes differs
signiﬁcantly from that for general cardiac patients. For
the professional athlete, player health and workman’s
compensation insurance policies are negotiated between
player unions and the sports franchises or leagues. In
general, cardiac screening (if required by overall league
cardiac policy or cardiovascular committee) is not covered
by insurance and is instead paid for directly by the teams
or league. If athletes require further evaluations, testing
is generally covered by insurance or team budgets (per-
sonal communications, Dr. Andy Tucker, National Foot-
ball League Cardiovascular Committee, September 27,2013). At the Division 1 collegiate level, athlete PPE and
any cardiac screening are paid for by the athletic depart-
ment. Further consultation or cardiac testing is reim-
bursed by athlete insurance policies. Although PPE is
required of high school student-athletes prior to sports
participation, the $25-$35 (average) cost often is paid for
by the parents. If a cardiac condition is suspected, then
additional testing is submitted to the student’s health
insurance plan. Payers can be key collaborators; their in-
terests can drive data gathering and allocation of re-
sources. Payers include athlete health insurance and
workman’s compensation carriers (for professional ath-
letes), event organizers, individual athletic departments,
and professional teams and leagues.
Industry: Industry partners can contribute tremen-
dously to the advancement of sports and exercise
cardiology through innovation and by making new tech-
nologies available to providers and patient-athletes.
Potential innovations include enhancing the ability of
existing clinical tools to detect underlying cardiac condi-
tions in athletes, and creating new tools to enhance the
ability to monitor athletes under conditions of sports.
Both individually and in partnership with researchers and
professional organizations, industry is able to assist with
standardization of cardiac testing protocols in athletes,
development of normative data, creation of interpretation
algorithms in American athletes, and support of registries.
Industry can also assist in communication with healthcare
providers and dissemination of information through
education.
TABLE 12 Advocacy and communications
Gap(s) Strategies and Methods Responsible Parties
Time
Frame
Lack of coordinated advocacy efforts
that have support of all stakeholders
providing athlete CV care
Create state-wide athlete CV care task forces.
1. Suggested members: AAP, AHA, ACC,
AAFP, school nurses association, PAs, state
high school activities associations, DHHS,
ATCs, state boards of education, key sports
medicine providers
2. Suggested areas for policy creation:
 Required use of current 4th PPE
forms (paper or electronic PPE)
 Which providers can perform PPEs?
 Providers performing PPEs be educated
and/or certiﬁed in cardiac assessment in
adolescents
 Cardiologist performing consultation
obtain education and/or certiﬁcation on
cardiac assessment in adolescents
 Every public and non-public school in
the state has 1 or more AEDs.
 All coaches, licensed ATCs, ADs,
administrators and school nurses be
trained in CPR and AED use;
 Each school must develop an Emer-
gency Action Plan (EAP)
 Details of the sudden death event must
be entered into a common registry
 Educate all student-athletes and their
parents/guardians on signs/symptoms
of SCA/SCD, and certify in writing that
they have been educated.
 All grade 7-12 school students are rec-
ommended to be trained in SCA/SCD,
CPR, and AED use
State chapters of AAFP, AANP, AAP, AAPA, ACC,
ACP, ACSM*, and AHA; NATA, key state sports
medicine physicians, school nurses, state high
school activities associations, DHHS, boards of
education, athletic directors, coaching staff,
athletes, educators, parents, public, and
media
2014-2015
Lack of standardization of screening methods Standardize best practices for screening
throughout the USA
1. Guidance provided by national professional
societies and professional organizations to
deﬁne “standards”
2. Standards include:
 If we screen, who, how, and why
we screen;
 RTP recommendations based on posi-
tive AHA elements, or test ﬁndings; and
 Attempts to reduce or eliminate
disparities in care.
3. Can be administered at state level
(see above task force plan for state
initiatives)
Healthcare provider professional and scientiﬁc
organizations: AAFP, AANP, AAP, AAPA,
ACC, ACP, ACSM, AHA, AMSSM, AOASM,
AOSSM, and NATA; school nurses, athletic
directors, and coaching staff; and sports
governing bodies
2016
Inconsistent messaging from American
professional groups
Enhanced communication among
major stakeholders
1. Convene mini-think tanks with
representatives from multidisciplinary
groups; meet regularly and report to
main Think Tank annually
2. Create interdisciplinary communications
methods: case discussion boards, listserves
3. Intermittent position statements from
stakeholders providing athlete CV care
Same as above plus: payers, industry, athletes,
educators, parents, public, legislators, and media
ongoing
AAFP indicates American Academy of Family Physicians; AAP, American Academy of Pediatrics; AANP, American Association of Nurse Practitioners; AAPA, American Academy of Physician
Assistants; ACC, American College of Cardiology; ACP, American College of Physicians; AD, athletic director; AED, automated external deﬁbrillator; AHA, American Heart Association;
AMSSM, American Medical Society for Sports Medicine; AOASM, American Osteopathic Academy for Sports Medicine; AOSSM, American Orthopaedic Society for Sports Medicine; ATC,
Certiﬁed Athletic Trainer; CPR, cardiopulmonary resuscitation; CV, cardiovascular; DHHS, Department of Health and Human Services; NATA, National Athletic Trainers Association;
PA, physician assistant; RTP, return to play; SCA, sudden cardiac arrest; and SCD, sudden cardiac death. *ACSM, American College of Sports Medicine and its 12 regional chapters.
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and media: In the absence of a universal electronic
athlete medical record, the athlete or parent may be the
only source of information regarding prior symptoms,
family history, cardiac evaluations, and procedures.
Athletes and parents need to be aware of theimportance of providing accurate information on the
PPE and to the screening examiner and team medical
staff. They need to be aware of how to recognize SCA
and its prodromal warning signs. Furthermore, as with
all care, athlete-patients and parents should be
educated about making informed decisions, which
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disclosure of risks related to participation in sports.
Methods for improving public awareness and outreach
can come from both the private and public sectors.
Legislators can be instrumental partners in these ef-
forts. Legislative pathways should be investigated and
pursued where cost-effective and sustainable methods
are proven, safe, and logical. Mass media is a critical
tool to educate the general public on PPE, screenings,
and risks versus beneﬁts to cardiac health through
participation in (or lack of participation in) athletic
endeavors. Partnering between the media, professional
organizations, and public advocacy groups is advisable
to ensure consistent messaging. Encouragement for
those with risk factors or symptoms to receive
comprehensive cardiac evaluations should be addressed
in a balanced manner in the media.
Critical Areas and Strategies for Action
As issues in younger athletes (#35 years old) have
received more attention and robust debate in recent years
than have issues facing older athletes, the Think Tank
discussion gravitated toward this younger group’s needs;
however, the general principles can be adapted to meet
the needs of older (>35 years old) athletes. The Think
Tank organizers selected 4 critical multidisciplinary do-
mains for which participants were charged with identi-
fying the most urgent gaps: 1) Quantifying risks to
American athletes; 2) Education, and optimal use of
existing clinical athlete care tools; 3) Research, quality,
and science; and 4) Advocacy and communications. Once
gaps were determined, speciﬁc strategies and methods
were designed to close those gaps, responsibilities were
assigned to speciﬁc stakeholders, and a time frame for
implementation was created. The time frame was meant
to convey the urgency of the issue as well as relative
priorities of different recommendations.
Quantifying Risks to American Athletes (Table 8)
Owing to athletic cardiac adaptations, the demands of
exercise, and the risks and beneﬁts of vigorous exercise,
athletes are considered a distinct patient group, requiring
tailored cardiovascular care and science devoted to their
unique needs (14,135,136). Regarding cardiac risks to
athletes, Think Tank participants deﬁned the most urgent
gaps as the need for sports cardiology metrics, for high-
quality epidemiologic research, and for education. True
cardiovascular risks to athletes are not known because
large, prospective, longitudinal cohort studies have not
been conducted in young athletic populations with sus-
pected low prevalence of disease, using well-deﬁned,
consensus-derived metrics. Retrospective studies of the
incidence of SCA/SCD in athletic populations have deliv-
ered variable results (42,44–46,75,76), perhaps owing todiffering deﬁnitions of SCA/SCD, varying methodologies,
incomplete data, and overlap with non-cardiac causes of
SCA/SCD. In any longitudinal study, the risks of partici-
pation, of cardiac testing and procedures, and of not
participating must be considered in the risk equation.
To tackle the question of cardiovascular risks to ath-
letes, Think Tank participants ﬁrst recommended that a
multidisciplinary panel of sports medicine and sports
cardiology experts convene to address the need to deﬁne
sports cardiology metrics. These metrics would include
whether to include SCA in the numerator of the SCD rate
equation, how to handle AED “saves” in data analysis,
and whether the numerator should be expanded from the
traditional “during or within an hour of physical activity”
to include “regardless of activity level.” Cohorts of ath-
letes could then be followed for cardiac events during
participation (activity-centered), as opposed to, longitu-
dinally (athlete-centered).
Going forward, investigators and those using the data
must be aware of differing metrics in the current litera-
ture. This is crucial because comparative effectiveness of
screening/testing/therapeutic strategies cannot be ach-
ieved without clear deﬁnition of the numerators and de-
nominators for outcomes. Experts must determine
whether identiﬁcation of an underlying high-risk condi-
tion is a meaningful outcome compared with a traditional
hard outcome such as SCA/SCD. These questions are
similar to what we have faced with other forms of
asymptomatic disease, such as silent ischemia in CAD, or
functional class 1 (Class A) heart failure/ cardiomyopathy.
Once the metrics have been deﬁned, prospective
athlete outcomes registries must be designed that are
sports speciﬁc and level speciﬁc, and that take into ac-
count athlete heterogeneity. If hard end-points occur at
low frequency in athletic populations, then softer cardiac
end-points such as arrhythmias, cardiac consultations,
hospitalizations, and need for cardiac procedures or
treatments, as well as perhaps sports medicine end-
points such as days off practice or out of competition
should be considered as alternative end-points. Risks of
cardiac testing and treatments, and the risks of a
sedentary lifestyle should also be factored into the risk
equation.
Education and Optimal Use of
Existing Clinical Athlete Care Tools (Table 9)
Think Tank participants identiﬁed urgent gaps in knowl-
edge of athlete cardiovascular care, conditions that place
athletes at risk, and risk mitigation strategies such as
hands-only CPR, recognition of SCA and its warning signs,
and optimal implementation of AEDs in schools and
athletic venues. To address these gaps, Think Tank par-
ticipants recommend immediate steps toward optimal use
of existing clinical tools through education and/or
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(at all levels). Federal Department of Transportation cer-
tiﬁcation, recently required by providers signing off on
commercial driver Department of Transportation physical
examination forms (137), serves as a good model for cer-
tiﬁcation. Non-formal certiﬁcations can be issued through
professional societies as a simple certiﬁcate of proﬁciency
in sports cardiology (for cardiologists), and/or perfor-
mance of PPEs (for primary care providers). Recom-
mended education includes knowledge and use of the 4th
PPE, 12 AHA elements, 36th Bethesda Conference guide-
lines, and Masters Athlete’s guidelines. Enhanced pres-
ence of existing clinical guidelines on the websites of all
national organizations and state chapters can immedi-
ately increase awareness of these clinical tools, and
knowledge and use of tools can be monitored through
performance improvement activities and continuing
medical education.
Beyond the promotion of existing clinical tools, Think
Tank participants encourage the development of core
competencies in sports and exercise cardiology and the
inclusion of basic sports cardiology competencies, as
appropriate to type of practice, in general certiﬁcation
exams for the following professional groups: cardiolo-
gists, sports physicians, primary care providers (pedia-
tricians and family practitioners, athletic trainers,
physician assistants, nurse practitioners, school nurses,
athletic directors, and coaching staff). The ACC Sports and
Exercise Cardiology Section has recently outlined its
vision for sports cardiology in the United States (14) and is
in the process of developing core competencies for both
adult and pediatric cardiologists.
At the local level, athlete cardiovascular care lends
itself particularly well to team-based approaches, which
provide the athlete with the expertise of all those with a
stake in athlete cardiovascular care across the contin-
uum. Gaps at multiple levels in knowledge of risk
mitigation strategies—such as hands-only CPR, recogni-
tion of SCA and its warning signs, optimal implementa-
tion of AEDs in schools and athletic venues—are probably
best addressed at the state level (see Advocacy
section). But a national coalition of professional organi-
zations can create an educational tool kit that can be
used by all 50 states to educate all stakeholders and
providers about primary and secondary prevention
strategies. Creation and distribution of public service
announcements at sporting events can promote hands-
only CPR and early application of the AED. Legislation
in all 50 states should be considered (see Advocacy
section).
Research, Quality, and Science (Table 10)
Think Tank participants recognized that the need for
rigorous research and meaningful data represented one ofthe most pressing and severe gaps in sports and exercise
cardiology. Areas of greatest immediate need are the un-
certain predictive value of symptoms; the lack of norma-
tive data in large populations of American athletes of
varying age, gender, race, ethnicity, size, and sport; the
lack of an evidence base for the traditional participation
guidelines; and major evidence gaps in the ECG screening
debate. The AHA screening guidelines are based on the
clinical presentation of underlying inherited diseases and
the ability of providers to recognize and act upon these
diseases (16). Although many data have been derived
from general populations, very little has been generated
in athletic populations (14) and nothing prospectively.
Therefore, we propose that the sports cardiology com-
munity promote and conduct research that examines the
predictive value of symptoms in athletes, aligns data
among disparate groups, and develops data-driven man-
agement algorithms. Importantly, the predictive value of
symptoms in athletes presenting to front-line providers
may be vastly different from that of symptoms in athletes
presenting to cardiologists.
Most of the athlete ECG data have been generated in
Europe, with very little generated in the United States.
Inherited diseases vary in incidence according to age,
gender, and race and ethnicity; thus, it may not be
appropriate to extrapolate data from Europe to the
United States. Moreover, sports such as American foot-
ball do not exist in Europe, so it is unlikely that European
ECG and echocardiographic data would be applicable to
this group. Normative data in American football need to
be reviewed and norms deﬁned for practical application.
The same is true for cardiac magnetic resonance imaging,
computed tomography, ambulatory monitoring, and
cardiopulmonary stress testing. Knowledge gaps can
potentially be closed through research evaluation of
large numbers of American athletes (level and sports
speciﬁc).
Once the value of symptoms and normative data for
cardiac testing has been described, data-driven man-
agement algorithms can be designed. Although man-
agement algorithms have been developed for relatively
healthy athletes, those with congenital, genetic or ac-
quired cardiac disease who wish to participate in ath-
letics (competitive or recreational) have special needs
that have not been well addressed in the past. Although
there have been guidelines (15) addressing participation
eligibility, a great number of adult patients choose,
with informed consent, to participate in activities that
some professionals feel are too dangerous. The concept
of informed consent and overall quality of life issues
for the athlete should be taken into account when
drafting such future guidelines; however, fully informed
consent implies there are some risk data to present to
the athlete with disease who hopes to participate. To
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counselled regarding the risk of aortic valve surgery
or heart transplant, an estimate of risk must be pre-
sented. This cannot be done without research-based
registries that include those with disease. The implant-
able cardioverter deﬁbrillator registry is a start, but
similar studies must be considered in all those with
disease who wish to participate. Other sports cardiology
research priorities have been outlined in a recent paper
from the ACC Sports and Exercise Cardiology Section
(Table 11) (14).
Advocacy and Communications (Table 12)
Think Tank participants determined that the most crucial
gaps in the United States included a lack of coordinated
advocacy efforts that have the support of all stakeholders
and that controversies regarding screening prevent
screening standardization throughout the United States,
resulting in inconsistent messaging from American pro-
fessional groups. To close these gaps, Think Tank partic-
ipants propose the creation of a coalition of national
American professional groups working in collaboration,
who would meet every 2 years to create uniform
standards and present a consistent, uniﬁed message to
providers. Recognizing that such policies are best imple-
mented on a state-by-state basis, the Think Tank also
recommends the creation of state-wide athlete cardio-
vascular care task forces.
Methods to improve student-athlete cardiovascular
care can originate in both the public and private sectors,
and from the grass roots to the federal level. Opportu-
nities exist down to the local level in terms of ordinances
and policies of municipal recreation departments,
although these measures are laborious and tend to be
highly variable in appearance. State level efforts seem to
be most realistic and attainable, as these models allow for
efﬁcient communication with all stakeholders and ﬁt
logically into existing healthcare delivery systems. We
suggest that multidisciplinary state-wide task forces be
formed in all 50 states, consisting of representatives
from: state chapters of the National Athletic Trainers
Association, AAP, AAFP, ACC, ACSM, AHA, school nurses
association, physician assistants, state high school activ-
ities/athletics associations, Department of Health and
Human Services, state boards of education, and medical
examiners. The goals of each task force will vary from
state to state, but advocacy efforts can be focused on the
following: setting standards as to who can perform the
PPE; requiring the 4th PPE in all states; and requiring
that providers performing PPEs or cardiac consultation
be educated and/or certiﬁed in cardiac assessment of
adolescents; that every public and non-public school in
the state has 1 or more AEDs; that all coaches, licensed
athletic trainers, athletic directors, administrators, andschool nurses be trained in CPR and AED use; that each
school develop an Emergency Action Plan (EAP); that
details of any SCA/SCD event be entered into a common
registry; that all student-athletes and their parents/
guardians be educated regarding the signs/symptoms of
SCA/SCD; and that all grade 7-12 school students have the
opportunity to be trained in SCA/SCD, CPR, and AEDs.
There is some evidence that state-based advocacy efforts
have been fruitful (21,24,126–128).
It is important to appreciate that each state must
evaluate the needs of its community and work closely
with professional organizations (participants in produc-
ing this document), to determine the appropriateness of
legislative initiatives on a state-by-state basis. Examples
of successful use of legislative initiatives include at least
1 piece of AED legislation in all 50 states (138) as well as
expansion of Good Samaritan legislation in other states.
On the federal level, the reality of legislative initiatives
does not seem as easy to achieve. The rural AED act has
received some funding in the past, but it remains a
battle to maintain funding levels. Although there are
currently bills in the House and Senate that will provide
both education on creating EAPs for schools in the event
of a cardiac emergency and SCA risk assessment tools to
school age children (HEARTS Act [139]), these initiatives
are slow-moving and have lacked public awareness and
support to aid their passage. In the private sector,
various nonproﬁt entities are seeking to improve cardiac
assessments and prompt access to deﬁbrillation. These
private initiatives raise awareness and, although well
meaning, may not fully address the needs of a particular
community owing to limited resources. Collaboration
and partnership between state and federal interests,
professional organizations, nonproﬁt organizations, and
patient advocacy organizations (all on state-by-state
basis, outlined above) offer the best chance for mean-
ingful change in policy practice and, ultimately, outcome
improvement in these areas.
Think Tank participants felt we could do a better job
at standardizing screening methods throughout the
United States. National professional societies and pro-
fessional organizations can improve efforts to deﬁne
“standards” and their implementation by addressing is-
sues including: if we screen, who we screen, how and
why we screen; RTP recommendations based on positive
AHA elements or test ﬁndings; and attempts to reduce or
eliminate disparities in care. Consideration should be
given to collating all major athlete participation guide-
lines (4th PPE, 36th Bethesda Conference, 12 AHA ele-
ments) into 1 guideline. This approach has merit because
a student athlete may be cleared by a primary care
provider, with or without cardiology consultation. This
will require coordination between all major professional
societies with a stake in athlete care. Guidance can be
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but implementation on a state-by-state basis is recom-
mended to achieve optimal distribution and effective-
ness. The coalition of national stakeholders, meeting on
a regular basis, can solve the problem of inconsistent
messaging.
Individual Athlete Advocacy
Resources should be allocated to provide education ef-
forts that ensure athletes know signs and symptoms as
well as how and to whom to report these concerns in a
manner they feel is safe and protects their conﬁdentiality.
In the context of community-based screening initiatives,
effectiveness must be weighed against the risk of false
reassurance and communicated to participants. Whether
screenings include history and physical alone or add
ECGs or echocardiograms, the value added and the
countervailing false positive/false negative rates should
be reported to participants in clearly comprehensible
language.
The minor athlete requires special consideration.
Choices made on behalf of a minor athlete by parents or
guardians are of special concern. The athlete’s choice to
participate may be overruled by parents, physicians, or
the governing body of the sport. Special attention should
be paid to the emotional needs of this population.
Advocacy and awareness efforts using mass media are
critical tools for educating the general public regarding
what they can and cannot expect from community-based
screenings as opposed to full clinical evaluation by a
cardiologist. Educational efforts addressing both the risks
and the beneﬁts to cardiac health presented by partici-
pation in (or lack of participation in) athletic endeavors,
both organized and recreational, should be enhanced and
communicated to the public. Encouragement for those
with risk factors to receive comprehensive cardiac eval-
uations should be addressed in a balanced manner in the
media.
SECTION 5. SUMMARY AND NEXT STEPS
The ACC Sports and Exercise Cardiology Think Tank was
convened to deﬁne the current cardiovascular issues and
needs of the American athlete and to develop an action
plan to guide future cardiovascular care efforts. Partici-
pants felt strongly that, rather than occurring as an iso-
lated event, our discussion should serve as the beginning
of an on-going dialogue and collaboration between highly
diverse stakeholders. Logical ﬁrst steps are listed below.
1. Development of a directory of the multiple partici-
pating organizations, with a list of ongoing and plan-
ned activities in the domain of athlete cardiovascular
safety. Activities could be classiﬁed as we havedone here: quantifying risk, education, optimal use of
existing tools, research, advocacy, and communica-
tions. This would allow for a comprehensive approach,
less duplication of efforts, greater speed and efﬁciency,
and optimal collaboration.
2. Commitment by the Think Tank participants to meet
regularly to discuss athlete cardiovascular care issues
and to disseminate Think Tank proceedings to their
respective organizations. Mini-think tanks with repre-
sentatives from key organizations could meet regularly
to discuss a particular subject, such as metrics, and
report their ﬁndings to the Think Tank annually or
every other year.
From our action plan, we have suggested the following
mini-think tanks or task forces would qualify as
priorities (in order of urgency):
a. Creating an athlete cardiovascular care task force in
each state
b. Promoting development of team-based care at local
levels (athletic trainers, team physicians, school
nurses, primary care providers, cardiologist and
cardiac subspecialists)
c. Developing evidence-based symptom management
d. Deﬁning normative data in American athletes: ECG,
echocardiography, magnetic resonance imaging,
computed tomography, ambulatory monitoring,
stress testing; closing knowledge gaps through
research involving large numbers of American ath-
letes (age level and sports speciﬁc)
e. Reviewing current sports cardiology metrics; pro-
posing additional end-points
f. Creating prospective athlete outcomes registries
linked to speciﬁc metrics
g. Optimizing implementation of existing clinical
tools through enhanced education and/or informal
certiﬁcation of multiple and diverse providers; in-
cludes knowledge and use of 4th PPE, 12 AHA ele-
ments, 36th Bethesda guidelines, masters athletes
guidelines
h. Creating competencies for all those involved in
athlete cardiovascular care that are appropriate to
type of practice, in collaboration with respective
professional societies and board examiners such as
cardiologists, sports physicians, primary care phy-
sicians (pediatrics and family medicine), athletic
trainers, physician assistants, advanced practice
nurses, school nurses, athletic directors, and
coaching staff
i. Educating athletes and all front-line providers about
warning signs and symptoms for early identiﬁcation
of SCA-related conditions, and about actual recog-
nition of SCA occurrence
j. Enhancing widespread availability of AEDs, devel-
oping EAPs, and promoting hands-only CPR
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2167Only through committed and focused collaboration can these
goals be achieved and the practical day-to-day cardiovascular
care of athletes be improved. For these efforts to be successful,
theymust be conductedbymultidisciplinary teamsofmedical
and nonmedical scientists, with support from professional
societies representing cardiology and its subspecialtiesprimary care and all its disciplines, sports medicine, and ath-
letic training. Our professional societies, funding agencies,
payers, and industry must be willing to invest in athlete car-
diovascular safety. It is hoped that these Think Tank pro-
ceedings will stimulate and support meaningful, continued
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APPENDIX 1. CONTINUED
APPENDIX 2. ABBREVIATIONS
AAFP ¼ American Academy of Family Physicians
AAP ¼ American Academy of Pediatrics
ACC ¼ American College of Cardiology
ACSM ¼ American College of Sports Medicine
AHA ¼ American Heart Association
AED ¼ automated external deﬁbrillator
CAD ¼ coronary artery disease
CP ¼ chest pain
CPR ¼ cardiopulmonary resuscitation
EAC ¼ exercise-associated collapse
EAP ¼ emergency action plan
ECG ¼ electrocardiogram
EMS ¼ emergency medical services
FHX ¼ family history
PPE ¼ Pre-participation evaluation
PVC ¼ Premature ventricular contractions
RTP ¼ return to play
SCA ¼ sudden cardiac arrest
SCD ¼ sudden cardiac death
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